Use of interleukin-1 to enhance the immune response of weakly immunogenic tumors.

摘要

There is described the use of IL-1 to enhance or induce an immune response to weakly or non-immunogenic tumors. Further described is a method of treating a weakly or non-immunogenic tumor in a mammal by treatment with IL-1 prior to cyto-reductive therapy such as radiation therapy or surgery.